Changeflow GovPing Healthcare FDA PRIA Reference Data
Routine Notice Added Final

FDA PRIA Reference Data

Favicon for www.regulations.gov Regs.gov: Food and Drug Administration
Published May 1st, 2024
Detected March 19th, 2026
Email

Summary

The FDA has published reference data related to the Prescription Drug User Fee Act (PRIA) for May 2024. This notice includes national employment data relevant to PRIA submissions. It serves as an informational update for regulated entities.

What changed

The Food and Drug Administration (FDA) has released PRIA Reference 5, dated May 2024, which includes national employment data. This data is likely intended to support or inform submissions made under the Prescription Drug User Fee Act (PRIA).

This document appears to be an informational notice providing reference data for drug manufacturers and medical device makers. No specific actions are mandated by this notice, and it does not appear to introduce new compliance obligations or deadlines. Regulated entities may find this data useful for their PRIA-related activities.

Source document (simplified)

Content

Download File

Download

Classification

Agency
FDA
Published
May 1st, 2024
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Drug manufacturers Medical device makers
Geographic scope
National (US)

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Pharmaceuticals Medical Devices

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.